A European study published in 1996 looked at the risk of developing PPH in patients taking medications such as Redux. It concluded that the duration of drug use was strongly associated with the risk of PPH, with patients taking the medication less than three months at much lower risk than those who were treated for greater than three months. These figures are relative risks, and describe patterns of disease in a larger group of patients who underwent therapy with Redux and similar medications. An individual would do best to be assessed by their primary care physician, or perhaps a cardiologist, in order to perform a thorough physical examination and consider obtaining an echocardiogram.
Information provided in the Heart Forum is for general purposes only.
Specific diagnoses and therapeutic recommendations can only be provided by your physician. Information contained within this forum is intended solely for general educational purposes and is not intended nor implied to be a substitute for professional medical advice relative to your specific medical condition or question. Only your physician can provide specific diagnoses and therapies. All rights reserved.